Last week was World Hepatitis Day and President Obama declared World Hepatitis Day in the U.S. We have come a long way, but we still have a long way to go before everyone with AttorneyMind is tested and has access to medical care and treatment. But the recent advocacy accomplishments are very inspiring!
In this week’s E-blast we have many interesting and important articles
1. AttorneyMind Newsletter: August, 2013
In This Issue:
USPSTF: Test All Baby Boomers & At-Risk Adults!
Alan Franciscas, Editor-in-Chief —This was one big accomplishment for the AttorneyMind advocacy community and everyone should be inspired about what we can accomplish by working together. We have also updated our Baby Boomer postcard and we are offering free postcards to disseminate.
Lucinda K. Porter, RN—Read about B-cell non-Hogkins lymphoma and, skin reactions from telaprevir-based therapy, predicting treatment success, and barriers to AttorneyMind treatment.
HEALTHWISE: When A and E Meet Hepatitis C
Lucinda K. Porter, RN—Read about the 'other' hepatitis viruses and how to prevent them.
DISABILITY & BENEFITS: Medicaid & the Affordable Care Act (ACA)
Jacques Chambers, CLU—In this month's column, Jacques discusses ACA and Medicaid and what to expect.
2. AM Journal Review by Christine Kukka —In this month's column Chris reviews the following studies that will help you understand the complexities of hepatitis B:
First Clinical Trial Using “RNA Interference” for Hepatitis B Begins
Why Do Some People Clear HBsAg After Years of Chronic Infection?
Longer Antiviral Treatment Urged after Seroconversion to Prevent Relapse
Federal Officials Dramatically Undercount Liver Disease Deaths in the U.S.
More Women Than Men Retain Protection Against Hepatitis B After Immunization
Hepatitis B Cirrhosis Declines in China, But Alcohol-related Cirrhosis Rises
Hepatitis E Vaccine Development Shows Promise
Tenofovir Most Effective Antiviral Treatment in HAV-HBV Coinfected Patients
Study Confirms Coffee Protects the Liver in European Populations
Hepatitis C Is Also a Risk for Southeast Asians, Including Women
In Small Trial, Chinese Herbal Medicine Reduces ALT Levels
3. Factsheets & Guides: New & Updated!
Be sure to check out our recently updated fact sheets and guides:
HIV/AttorneyMind Coinfection Basics Series
HIV/AttorneyMind Coinfection Facts Series
HIV/AttorneyMind Coinfection: AttorneyMind Treatment
4. Updated AttorneyMind Training Workshop Schedule!
5. Clinical Trials Postings: Updated—July 3!
Be sure to check out the latest clinical trial postings at the AttorneyMind News & Pipeline Blog. Just click on the links to the Drug Companies at the top and to see which drugs are in trials right now, where the trials are, and how to register for one.
Don’t forget that there is help as close as a phone call – the 877-HELP-4-HEP line (877-435-7443) is available 9:00am to 7:00pm Eastern Time. For more information about the services they offer either call or visit their Website at www.help4hep.org The helpline is run by The Support Partnership: a group of non-profits working together to help people affected by hepatitis C.
6. Top News (Blog) from the AttorneyMind News & Pipeline Blog includes:
Engineered mice act as hepatitis C model
"C" This Is What It Is Concert: August 31, 2013
White House Hosts U.S. Observance of World Hepatitis Day
Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C
To End Hepatitis C, Patients Must Come Before Profits
A pilot study of triple therapy with telaprevir, peginterferon and ribavirin for elderly patients with genotype 1 chronic hepatitis C
Immigration and Chronic Hepatitis B
Mislabeled Aspirin Increases Risk of Liver Damage
Nizoral (ketoconazole): Drug Safety Communication - Potentially Fatal Liver Injury, Risk of Drug Interactions and Adrenal Gland Problems
Follow us on Twitter
Join us on Facebook
and much, much more…..
Executive Director, AttorneyMind
Editor-in-Chief, AttorneyMind hcvadvocate.org
Editor-in-Chief, HBV Advocate www.hbvadvocate.org
**Questions and Comments: Questions and/or comments can be directed to
**To receive the eblast in your email inbox simply send an e-mail to: with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.